BAYERCROP — Bayer Cropscience Income Statement
0.000.00%
- IN₹244.98bn
- IN₹236.74bn
- IN₹54.73bn
- 73
- 15
- 33
- 33
Annual income statement for Bayer Cropscience, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 42,613 | 47,344 | 51,397 | 51,032 | 54,734 |
Cost of Revenue | |||||
Gross Profit | 17,834 | 20,356 | 22,726 | 21,420 | 20,746 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 35,073 | 39,187 | 41,813 | 42,118 | 48,687 |
Operating Profit | 7,540 | 8,157 | 9,584 | 8,914 | 6,047 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 7,945 | 8,468 | 9,901 | 9,414 | 7,074 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4,931 | 6,453 | 7,582 | 7,405 | 5,680 |
Net Income Before Extraordinary Items | |||||
Net Income | 4,931 | 6,453 | 7,582 | 7,405 | 5,680 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 4,931 | 6,453 | 7,582 | 7,405 | 5,680 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 108 | 134 | 151 | 169 | 126 |
Dividends per Share | |||||
Special Dividends per Share |